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Potassium (K+) channels are expressed in almost every cells and are ubiquitous in
neuronal and glial cell membranes. These channels have been implicated in different
disorders, in particular in epilepsy. K+ channel diversity depends on the presence
in the human genome of a large number of genes either encoding pore-forming or
accessory subunits. More than 80 genes encoding the K+ channels were cloned and
they represent the largest group of ion channels regulating the electrical activity of cells
in different tissues, including the brain. It is therefore not surprising that mutations in
these genes lead to K+ channels dysfunctions linked to inherited epilepsy in humans
and non-human model animals. This article reviews genetic and molecular progresses
in exploring the pathogenesis of different human epilepsies, with special emphasis on
the role of K+ channels in monogenic forms.
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INTRODUCTION
Epilepsy is one of the most common neurological disorders characterized by abnormal electrical
activity in the central nervous system (CNS) and recurrent seizures represent a cardinal clinical
manifestation. The phenotypic expression of each seizure is determined by the original point of the
hyperexcitability and its degree of spread in the brain (Steinlein, 2004). Several brain defects due to
membrane instability could cause epilepsy.
In the last two decades, gene defects underlying different forms of epilepsy have been
identified and most of these genes code for ion channels, which thus appear as important players
in the etiopathogenesis of idiopathic epilepsy. Indeed, several epileptic phenotypes have been
associated to dysfunctions of potassium (K+) channels (Brenner and Wilcox, 2012). It has been
recently proposed to name such epilepsies as “K+ channelepsies” (D’Adamo et al., 2013). These
channels play a major role in neuronal excitability and their importance is related to the level of
their expression in subcellular domain, individual cell, or circuit (Cooper, 2012). K+ channels
are also involved in setting the inward-negative resting membrane potential. Based on their
structures, biophysical characteristics, pharmacological sensitivities and physiology, these channels
are classified as voltage-gated (Kv), inwardly rectifying (Kir), sodium (Na)-activated channels or
Ca2+-activated channels (Table 1; González et al., 2012).
Herein we report an updated discussion on the role of mutations in K+ channels (Table 2) in
the pathogenesis of human epilepsy.
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TABLE 1 | Summary of human K+ channels subfamilies involved in epilepsies.
Subfamily Main functions Cloned
subunits
Subunits associated
with epilepsy
Voltage-gated K+ channels (Kv) Regulation of outward K+ currents and action potentials, modulation of
neurotransmitter release, control of both excitability and electrical
properties of neurons
Kv1-12 Kv1.1; Kv1.2
Kv4.2; Kv4.3
Kv7.1; Kv7.2; Kv7.3
Kv8.2
Kv11.1
Inwardly rectifying K+ channels (Kir) Maintenance of the resting membrane potentials and regulation of the
cell excitability
Kir1-7 Kir2.1
Kir4.1
Kir6.2
Sodium-activated K+ channels (KNa) Regulation of delayed outward currents IKNa and contribution to
adaptation of firing rate
KCa4.1 (Slack)
KCa4.2 (Slick)
KCa4.1 (Slack)
Calcium-activated K+ channels (KCa) Regulation of neuronal firing properties and circuit excitability KCa1−3
KCa5.1
KCa1.1
VOLTAGE-GATED K+ CHANNELS (Kv)
The Kv channels are widely expressed both in the central
and in peripheral nervous system where they are involved in
several processes (e.g., the regulation of the duration of action
potentials, the modulation of the neurotransmitter release, the
control of the electrical properties and the firing of neurons).
Kv channels generally regulate outward K+ currents that
contribute to membrane repolarization and hyperpolarization,
thus limiting the neuronal excitability. Moreover, they actively
participate in cellular and molecular signaling pathways that
regulate the life and death of neurons, such as apoptosis,
channel phosphorylation, or cell proliferation (Shah and
Aizenman, 2014). In particular, neuronal cell apoptosis is
correlated to an increased expression of Kv channels at the
plasma membrane, thus facilitating more K+ eﬄux and a
loss of cytosolic K+. This drop in the intracellular K+
concentration actives pro-apoptotic enzymes, such as nuclease
or caspase that can trigger downstream apoptotic signals
culminating in DNA fragmentation or degradation (Leung,
2010).
In human genome, forty different genes encoding for
Kv channels were reported and subdivided into twelve
sub-families (Kv1 through Kv12) (Gutman et al., 2005).
Mammalian Kv channels are tetramers, composed of α-subunits
that line an ion pore. Each α-subunit shows six α-helical
transmembrane domains (S1–S6), a membrane-reentering P
loop between S5 and S6, and cytosolic N-, and C-termini.
The S5-P-S6 segments constitute the ion conduction pore,
while the S1–S4 sequences are critical for the voltage-
sensing and gating of the channel (Brenner and Wilcox,
2012).
Furthermore, α-subunits can bind to regulatory β subunits
(Kvβ1, Kvβ2, and Kvβ3) as well as to other Kv channel-interacting
proteins. This variability in the channel interactions results in
strong modifications of the channel properties (McKeown et al.,
2008).
The following Kv subfamilies have been associated with either
epilepsy or other disorders showing seizures.
Kv1
The Kv1 subfamily plays an essential role in the initiation and
shaping of action potentials. These channels are expressed
at the soma, axons, synaptic terminals, and proximal
dendrites. The most abundant Kv1 α-subunits are Kv1.1,
Kv1.2, and Kv1.4. These subunits are differentially expressed
and their composition is dependent upon the brain region,
cell type and subcellular localization (Robbins and Tempel,
2012).
Heterozygous mutations in the KCNA1 gene, encoding the
Kv1.1 α subunit, were associated with episodic ataxia type
1 (EA1), a dominantly inherited disorder characterized by
generalized ataxia attacks and spontaneous muscle quivering
(Browne et al., 1994). Interestingly, a subset of patients with
familial EA1 shows epileptic seizures, suggesting that Kv1.1
dysfunctions may play a role in the pathophysiology of epilepsy
(Spauschus et al., 1999; Zuberi et al., 1999; Eunson et al.,
2000). Loss-of function mutations reported in the KCNA1
gene of EA1 patients cause reduced current amplitude thus
contributing to seizures susceptibility (Browne et al., 1994;
Adelman et al., 1995; D’Adamo et al., 1999; Imbrici et al.,
2006).
In support of the hypothesis of an epileptogenic role of
KCNA1 mutations, several knock-out mouse models for this
gene developed an epileptic phenotype (Smart et al., 1998; Rho
et al., 1999). Biochemical and biophysical studies demonstrated a
colocalization of Kv1.1 and Kv1.2 subunits in several subcellular
brain regions and that they could form heteromeric channels,
which are reported as profoundly altered by EA1 mutations
(D’Adamo et al., 1999).
Notably, a Kv1.2 knock-out mouse model displayed increased
seizure susceptibility (Brew et al., 2007). In this regard, Syrbe
et al. (2015) recently identified de novo loss or gain-of-function
mutations in KCNA2 gene (Table 2), encoding the Kv1.2 channel,
in patients showing mild to severe epileptic encephalopathy.
A role of Kv1.2 was also suggested by another case report
describing a de novo mutation, leading to the p.Arg297Gln amino
acid substitution in a patient affected by ataxia and myoclonic
epilepsy (Pena and Coimbra, 2015).
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TABLE 2 | Mutations in K+ channels associated with human epileptic phenotypes.
Gene/protein Epileptic phenotypes Mutations Effects on channel
functionality
Reference
KCNA1/Kv1.1 Generalized or partial
seizures associated to
EA1
Several heterozygous point mutations Loss-of-function mutations
altering the channel’s properties
and frequently associated with
reduced currents
Browne et al., 1994; Adelman et al., 1995;
D’Adamo et al., 1999; Spauschus et al.,
1999; Zuberi et al., 1999; Eunson et al.,
2000; Imbrici et al., 2006;
KCNA2/Kv1.2 Mild to severe epileptic
encephalopathy
p.Ile263Thr
p.Arg297Gln
p.Leu298Phe
p.Pro405Leu
Loss-of-function
Gain-of-function
Gain-of-function
Loss-of-function
Syrbe et al., 2015
Ataxia and myoclonic
epilepsy
p.Arg297Gln Functional analysis are under
way
Pena and Coimbra, 2015
KCND2/Kv4.2 TLE p.Asn587fsX1 Channel haploinsufficiency due
to truncated Kv4.2 subunit
Singh et al., 2006
Autism and severe
intractable seizures
p.Val404Met Gain-of-function mutation
showing
slowed channel inactivation
Lee et al., 2014
KCND3/Kv4.3 Early onset cerebellar
ataxia, intellectual
disability, oral apraxia
and epilepsy
p.Arg293_Phe295dup Strong shift of the
voltage-dependence of
activation and inactivation of
the channel subunit
Smets et al., 2015
KCNQ1/Kv7.1 LQTS and epilepsy p.Leu273Phe No available data on channel
functionality
Tiron et al., 2015
SUDEP p.Ala46Thr
p.Val287Met
p.Val648Ile
p.Ala46Thr: activation of more
rapid current without initial
delay
Yang et al., 2009; Partemi et al., 2015
KCNQ2/Kv7.2 BFNS with normal
cognition or
EOEEs with mental
retardation
> 80 mutations (missense, non-sense,
truncations, splice-site defects,
frame-shift mutations, sub-microscopic
deletions or duplications)
Impairment of channel function,
leading to reduced current
densities
Singh et al., 1998; Weckhuysen et al.,
2012; Soldovieri et al., 2014
KCNQ3/Kv7.3 BFNS with variable age
of onset and good
outcome
p.Gly340Val
p.Arg780Cys
No available data on channel
functionality
Zara et al., 2013;
Grinton et al., 2015
Early-onset epilepsy
and neurocognitive
deficits
p.Ile317Thr
p.Arg330Leu
Impairment of channel function,
leading to reduced current
densities
Soldovieri et al., 2014;
Miceli et al., 2015
BECTS p.Arg364His No available data on channel
functionality
Fusco et al., 2015
KCNV2/Kv8.2 Febrile and afebrile
partial seizures
p.Arg7Lys Decrease in delayed rectifier K+
current in neurons
Jorge et al., 2011
Epileptic
encephalopathy and
severe refractory
epilepsy
p.Met285Arg Decrease in delayed rectifier K+
current in neurons and
impairment of the
voltage-dependence of the
channel
Jorge et al., 2011
KCNH2/Kv11.1 Epilepsy associated
with LQT2
p.Ile82Thr
p.Arg176Trp
p.Thr74ArgfsTer32
p.Ala429Pro
p.Tyr493Phe
p.Arg534Cys
p.Arg863X
p.Arg1047Leu
Loss-of-function mutations,
leading to reduced currents
Keller et al., 2009; Omichi et al., 2010; Tu
et al., 2011; Zamorano-León et al., 2012;
Partemi et al., 2013
(Continued)
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 March 2016 | Volume 10 | Article 81
fncel-10-00081 March 26, 2016 Time: 12:52 # 4
Villa and Combi Potassium Channels in Epilepsy
TABLE 2 | Continued
Gene/protein Epileptic phenotypes Mutations Effects on channel
functionality
Reference
KCNAB2/Kvβ2 Severe epilepsy hemizygous deletion of KCNAB2 Loss-of-function mutations/
haploinsufficiency
Heilstedt et al., 2001
LGI1 ADLTE > 30 mutations
(missense, splice-site mutations, short
indels,
Failure in preventing channel
inactivation resulting in more
Kalachikov et al., 2002; Morante-Redolat
et al., 2002; Nobile et al., 2009;
single microdeletion) rapidly closing channels Fanciulli et al., 2012; Dazzo et al., 2015
KCNJ2/Kir2.1 Seizures associated
to ATS
p.Arg67Gln
p.Gly146Ser
p.Thr192Ile
Loss-of-function mutations with
dominant-negative effects
Haruna et al., 2007; Chan et al., 2010
SQT3s and
autism-epilepsy
phenotype
p.Lys346Thr Gain-of-function mutation
leading to enhance the
channel’s surface expression
and stability at the plasma
membrane, reduce protein
degradation and alter protein
compartmentalization
Ambrosini et al., 2014
KCNJ10/Kir4.1 Seizure susceptibility p.Arg271Cys No observable changes in
channel function or in predicted
channel structure
Buono et al., 2004;
Shang et al., 2005
Epilepsy associated to
EAST or SeSAME
syndrome
p.Arg65Cys
p.Arg65Pro
p.Phe75Lys
p.Gly77Arg
p.Val259fs259X
Loss-of-function recessive
mutations
Bockenhauer et al., 2009; Scholl et al.,
2009; Freudenthal et al., 2011
Epilepsy associated to
ASDs and intellectual
disability
p.Arg18Gln p.Val84Met Gain-of-function mutations
leading to increased channel
surface expression
Sicca et al., 2011
KCNJ11/Kir6.2
ABCC8/SUR1
DEND syndrome Several point mutations Gain-of-function mutations
causing reduction in ATP
sensitivity, leading to an
increase in the KATP current
Hattersley and Ashcroft, 2005
KCNT1/Slack ADNFLE associated to
intellectual disability
and psychiatric features
p.Gly288Ser
p.Arg398Gln
p.Tyr796His
p.Met896Ile p.Arg928Cys
Gain-of-function mutations,
increasing the cooperativity in
channel gating
Heron et al., 2012; Kim et al., 2014; Møller
et al., 2015
EIMFS p.Val271Phe
p.Gly288Ser
p.Arg398Gln
p.Arg428Gln
p.Arg474His
p.Met516Val
p.Lys629Asn
p.Ile760Met
p.Pro924Leu
p.Ala934Thr
Gain-of-function mutations,
increasing the cooperativity in
channel gating
Barcia et al., 2012; Ishii et al., 2013; Kim
et al., 2014; Mikati et al., 2015; Møller et al.,
2015; Ohba et al., 2015; Rizzo et al., 2016
EOEEs p.Phe932Ile No available data on channel
functionality
Vanderver et al., 2014
OS p.Ala966Thr Gain-of-function mutation Martin et al., 2014;
Kim et al., 2014
KCNMA1/KCa1.1 Generalized epilepsy
and paroxysmal
dyskinesia
p.Asp434Gly Gain-of-function mutation
leading to an increase of
channel opening probability and
Du et al., 2005; Lee and Cui, 2009
Ca2+ dependence
(Continued)
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TABLE 2 | Continued
Gene/protein Epileptic phenotypes Mutations Effects on channel
functionality
Reference
KCNMB3/ KCaβ3 Idiopathic generalized
epilepsy
p.Val256TyrfsTer4 Loss-of-function truncation
mutation affecting synaptic
inhibition and increasing
neuronal excitability
Hu et al., 2003; Lorenz et al., 2007
Kv4
The Kv4 channels are highly expressed in the brain and mediate
the main dendritic A-currents which critically regulate action
potential back-propagation and the induction of specific forms
of synaptic plasticity. In particular, the Kv4.2 subunit is a key
component of the A-type potassium current in the CNS (IA)
(Birnbaum et al., 2004).
In 2006, Singh and collaborators described a truncation
mutation (p.Asn587fsX1) in the Kv4.2 channel encoded by
the KCND2 gene, in a patient affected by temporal lobe
epilepsy (TLE). This mutation causes a frame-shift, leading to
a premature termination codon and consequently to a Kv4.2
channel haploinsufficiency (Singh et al., 2006). Recently, a whole
exome sequencing study identified a de novo gain-of-function
mutation (p.Val404Met) in KCND2. The mutation was found
in monozygotic twins affected by autism and severe intractable
seizures and occurred at a highly conserved residue within the
C-terminus of the S6 transmembrane region of the ion pore.
A functional analysis of mutated channels revealed a significantly
slowed channel inactivation (Lee et al., 2014).
Very recently, an involvement of Kv4.3 subunits in epilepsy
was also suggested by the identification of a de novo mutation
(p.Arg293_Phe295dup) in the relevant KCND3 gene causing a
severe channel dysfunction in a patient with complex early onset
cerebellar ataxia, intellectual disability, oral apraxia and epilepsy.
This mutation results in the duplication of a RVF (Arginine–
Valine–Phenylalanine) motif in the S4 segment and leads to
a more positively charged voltage-sensor domain, altering the
voltage-dependent gating properties of the channel. In details, the
p.Arg293_Phe295dup mutation induced a strong depolarizing
shift in the voltage dependence of both the activation (about
+59.3 mV) and inactivation (+62 mV) of the channel (Smets
et al., 2015).
Kv7
KCNQ (Kv7) channels are low-threshold activated voltage-gated
potassium channels. Among the five known isoforms, KCNQ2–5
are expressed throughout the nervous system, whereas KCNQ1
is mostly expressed in cardiac tissue. The KCNQ2 gene is the
most commonly reported as mutated in epilepsy. Its mutations
cause neonatal epilepsies with wide phenotypic heterogeneity,
ranging from benign familial neonatal seizures (BFNS) with
normal cognition and unremarkable neuroimaging to early onset
epileptic encephalopathies (EOEEs) with mental retardation,
suppression-burst electroencephalography (EEG) and distinct
neuroradiologic features (Singh et al., 1998; Weckhuysen
et al., 2012; Soldovieri et al., 2014). More than 80 different
mutations in KCNQ2, consisting of missense, non-sense,
truncations, splice site defects and frame-shift mutations,
as well as sub-microscopic deletions or duplications, were
described and most of them are found in the pore region and
the large intracellular C-terminal domain (Lee et al., 2009).
Functional studies suggested a strict phenotype/genotype
correlation between disease severity and functional properties
of mutant channels (Miceli et al., 2013). KCNQ2 is a primary
player that mediates neuronal muscarinic (M) currents: the
opening of this channel or of heterogeneous KCNQ2/KCNQ3
complexes inhibits initiation of action potential and thus
suppresses neuronal excitability (Brown and Passmore,
2009).
Mutations in KCNQ3 gene have been described in families
affected with benign epilepsy with variable age of onset and
good outcome (Zara et al., 2013; Grinton et al., 2015) or in
a patient with benign childhood epilepsy with centrotemporal
spikes (BECTS) (Fusco et al., 2015). However, two recent
reports suggested that mutations in KCNQ3, similarly to KCNQ2,
can be also found in patients with more severe phenotypes,
including intellectual disability. In particular, they described
KCNQ3 mutations in patients with early onset epilepsy and
neurocognitive deficits (Soldovieri et al., 2014; Miceli et al., 2015;
Table 2).
Mutations in the KCNQ1 gene were associated with a
particular form of long QT syndrome, the LQT1 (Wang
et al., 1996). Interestingly, some authors observed that epilepsy
occurred in mouse lines bearing dominant human LQT1
mutations in this channel, which caused syncope and sudden
death (Goldman et al., 2009). Moreover, genetic variants in the
KCNQ1 gene were reported in three cases of sudden unexpected
death in epilepsy (SUDEP), a catastrophic complication of
human idiopathic epilepsy with unknown causes. However, the
relationship of these variants to the disease remains to be
elucidated (Yang et al., 2009; Partemi et al., 2015). The evidence
that KCNQ1 genetic variations may confer susceptibility for
recurrent seizure activity increasing the risk of sudden death is
further supported by the description of a pathogenic KCNQ1
variant (p.Leu273Phe) in a family featuring LQTS and epilepsy
(Tiron et al., 2015).
Kv8
The KCNV2 gene encodes the voltage-gated K+ channel Kv8.2.
This subunit is electrophysiologically silent when assembled in
homotetramer. Otherwise, it significantly reduces the surface
expression of the resulting channels and influences their
biophysical properties when involved in the formation of
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functional heterotetramers with Kv2 subunits (Czirják et al.,
2007). Kv2.1 and Kv8.2 show significant regional overlap: within
the hippocampus, transcripts for both KCNV2 and KCNB1,
which encodes Kv2.1, are detected in excitatory neurons of the
pyramidal cell layers and the dentate gyrus. Similarly, both of
them are abundantly expressed in the cortex (Maletic-Savatic
et al., 1995). Their regional colocalization is consistent with an
effect of Kv8.2 variants on Kv2.1 channels within cells critically
important for seizure generation and propagation.
A support of the involvement of KCNV2 in seizure
pathogenesis was provided by the identification of non-
synonymous variants in two unrelated children showing epilepsy:
p.Arg7Lys and p.Met285Arg. In particular, the p.Arg7Lys was
found in a patient affected by febrile and afebrile partial seizures,
whereas the p.Met285Arg was reported in a case of epileptic
encephalopathy and severe refractory epilepsy. The functional
characterization of these variants demonstrated that they
both enhanced Kv8.2-mediated suppression of Kv2.1 currents,
suggesting a role in decreasing delayed rectifier K+ current
in neurons, therefore increasing cells excitability. Moreover,
the p.Met285Arg caused a shift in the voltage-dependence of
activation as well as slower activation kinetics, in accordance with
the more severe clinical phenotype of the patient (Jorge et al.,
2011).
Kv11-HERG
The human ether-a-go-go-related gene (hERG, also known
as KCNH2) encodes the pore-forming subunit of the rapid
component of the delayed rectifier K+ channels, Kv11.1, which
are expressed in several tissues, mostly in brain and heart. In the
brain, Kv11.1 channels regulate neuronal firing and modulate the
excitability of GABAergic and dopaminergic neurons. The same
channel exerts a different function in the heart being involved
in the regulation of membrane potentials in the ventricles
(Vandenberg et al., 2012).
Mutations in the KCNH2 gene were reported to cause
type 2 long QT syndrome (LQT2), a rare inherited ion
channel disorder characterized by prolonged QT interval and
predisposing patients to ventricular arrhythmias that can lead
to syncope and sudden cardiac death (SCD). LQT2 syndrome
is frequently misdiagnosed as epilepsy due to seizures that
are triggered by cerebral hypoperfusion during a ventricular
arrhythmia, therefore suggesting a possible link between epilepsy
and cardiac arrhythmias, as described by several clinical reports
(Johnson et al., 2009; Keller et al., 2009; Omichi et al., 2010;
Tu et al., 2011; Zamorano-León et al., 2012; Partemi et al.,
2013). In particular, a seizure phenotype was reported in about
30% of unrelated LQTS patients carrying pathogenic variants
in the KCNH2 gene, suggesting that mutations in the Kv11.1
channel associated with LQTS may also predispose to seizure
activity (Johnson et al., 2009). Moreover, a post-mortem study
identified nearly 13% of LQTS pathogenic variants in the
KCNH2 and SCN5A genes in epileptic samples. In particular,
regarding KCNH2, two non-synonymous mutations have been
identified: p.Arg176Trp and p.Arg1047Leu (Tu et al., 2011).
Another study on three families showing a history of seizures
and LQTS2 lead to the identification of three novel KCNH2
mutations: p.Tyr493Phe, Ala429Pro and Thr74ArgfsTer32 (also
named p.del234-241). In vitro functional analyses of all these
variants showed a loss of hERG potassium channel function
with a reduction of the current, suggesting a dominant
negative effect (Keller et al., 2009). Omichi et al. (2010)
reported a case of a man with long history of epilepsy and
referred for cardiologic evaluation, showing the p.Arg534Cys
mutation. In addition, other authors identified a nonsense
mutation (p.Arg863X) leading to a 296-amino acid deletion
(Zamorano-León et al., 2012) while a loss-of-function mutation
(p.Ile82Thr) was reported in a pedigree featuring LQTS,
idiopathic epilepsy and increased risk of sudden death (Partemi
et al., 2013).
AUXILIARY SUBUNITS OF Kv
CHANNELS
Kv channel functional diversity is enhanced by coassembly
with a wide array of auxiliary subunits, which cannot form
functional channels alone but which can greatly impact channel
function upon coassembly with α-subunits to form hetero-
oligomeric complexes (Trimmer, 1998). Defects in these subunits
may affect Kv channel function and network excitability,
resulting thus in an increase of seizure susceptibility. Several
subunits have been identified, including β-subunit (Kvβ), leucine-
rich glioma-inactivated-1 (KvLGI1) and K+ channel-interacting
protein (KvKChIP).
Kvβ
Kvβ subunits are cytoplasmatic proteins critical for the correct
membrane localization and normal biophysical properties of
voltage-gated K+ channels. Variations in the expression of
different Kvβ genes and their isoforms could significantly impact
K+ channel function, especially with respect to inactivation
kinetics. In the mammalian genome three genes encode
Kvβ subunits: Kvβ1, Kvβ2, and Kvβ3 (Pongs and Schwarz,
2010). Interestingly, Kvβ2 knockout mouse models were
characterized by cold-swim induced tremors and occasional
seizures, suggesting thus a role of this subunit in the
regulation of neuronal excitability (McCormack et al., 2002).
An association between the severity of seizures and the loss-of-
function of the KCNAB2 gene that encodes the β2 subunit was
reported (Heilstedt et al., 2001). In particular, the hemizygous
deletion of KCNAB2 identified in this manuscript in epileptic
patients suggested that haploinsufficiency of this gene may
represent a significant risk factor for epilepsy: the lack of
the β subunit would reduce K+ channel-mediate membrane
repolarization and increase neuronal excitability (Heilstedt et al.,
2001).
KvLGI1
The leucine-rich glioma-inactivated-1 (LGI1) is the best
characterized LGI family protein, highly expressed in neurons,
which encodes a secreted protein containing two domains [a
leucine-rich repeat domain (LRR) and a β-propeller domain
called EPTP] that mediate protein-protein interactions. LGI1
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binds to the presynaptic voltage-gated potassium channel Kv1.1
and prevents Kv channel inactivation mediated by the β subunit
of the channel (Schulte et al., 2006). The LG1 gene was find
to be mutated in approximately 50% of ADLTE (autosomal
dominant lateral TLE) families: more than 30 disease-causing
mutations in LGI1 gene have been associated so far with
this focal epilepsy that is characterized by good response to
antiepileptic drugs and with a juvenile onset (Kalachikov et al.,
2002; Morante-Redolat et al., 2002; Dazzo et al., 2015). In
particular, almost all mutations are missense, splice-site, or short
indels (Nobile et al., 2009; Ho et al., 2012) while only a single
microdeletion has been reported (Fanciulli et al., 2012). Certain
LGI1 mutants (typically non-secreted mutants) fail to prevent
channel inactivation resulting in more rapidly closing channels,
which extends presynaptic depolarization and leads to increased
calcium (Ca2+) influx. Consequently, release of neurotransmitter
is increased excessively and may induce focal seizures (Nobile
et al., 2009). Moreover, it was demonstrated that the loss of LGI1
gene in mice induced lethal epilepsy, suggesting its essential
role as an antiepileptogenic ligand. LGI1 may serve as a major
determinant of brain excitation and the LGI1 gene-targeted
mouse could provide a good model for human epilepsy (Fukata
et al., 2010).
KvKChIP
The K+ channel-interacting proteins (KChIPs 1–4) compose
a subfamily of neuronal Ca2+ sensor proteins that modulate
trafficking, targeting to the plasma membrane, as well as
turnover and endocytosis of Kv4 channels (An et al., 2000).
Among KChIPs, KChIP2 is abundantly expressed in hippocampal
pyramidal cells and represents the major target of Kv4 α subunits
to form a complex essential for IA regulation in hippocampal
neurons (Rhodes et al., 2004). This current has been found to
be reduced in the presence of a deletion in the KChIP2 gene
by Wang and collaborators. The authors thus suggested that
it may increase susceptibility to seizures (Wang et al., 2013).
Moreover, they also hypothesized a role of KChIP2 in SUDEP
risk (Wang et al., 2013), since KChIP2 knockout mice were
previously shown to be highly susceptible to induced arrhythmias
(Kuo et al., 2001). In conclusion, these data suggested that loss-
of-function mutations in modulatory subunits could increase
the susceptibility to seizures and cardiac arrhythmias, thereby
providing a unified mechanism for a neurocardiac syndrome
such as SUDEP.
INWARDLY RECTIFYING POTASSIUM
CHANNELS
Inwardly rectifying K+ (Kir) channels are widely expressed in
several excitable and non-excitable tissues playing a key role
in the maintenance of the resting membrane potential and
consequently in the regulation of cell excitability. Approximately
15 Kir clones forming either homotetramers or heterotetramers
were identified and grouped in seven different families based
on sequence similarity and functional properties: Kir1-Kir7
(Hibino et al., 2010). Generally, Kir channels showed the greater
conductance at negative potentials in respect to the equilibrium
potential for K+ (EK), while an inhibition of the outward flow of
K+ ions caused by both Mg2+ and polyamines was reported at
more positive values (Lopatin et al., 1994). Several Kir channels
have been associated with epileptic phenotypes and, in particular,
Kir2.1, Kir3, Kir4 and Kir6.
Kir2.1
The Kir2.1 channel is encoded by the KCNJ2 gene whose
expression is reported in several brain areas (Karschin et al., 1996)
as well as in astrocytes where they control astrocyte-mediated K+
buffering in combination with Kir4.1 (Jabs et al., 2008; Chever
et al., 2010).
Several mutations impairing the channel functionality were
reported in the KCNJ2 of Andersen–Tawil syndrome (ATS)
patients (Haruna et al., 2007; Chan et al., 2010; Guglielmi
et al., 2015; see Table 2 for mutation details). On the other
hand, Kir2.1 gain-of-function mutations cause the type-3 variant
of the short QT syndrome (SQT3s) which results in QT
shortening and increased risk of sudden cardiac death (Priori
et al., 2005). Recently, some authors detected a novel mutation
(p.Lys346Thr) in the KCNJ2 in monozygotic twins displaying
SQT3s and autism-epilepsy phenotype, suggesting the existence
of a Kir2.1 role in neuropsychiatric disorders and epilepsy.
Functional studies revealed that this mutation causes an increase
of the channel’s surface expression and stability at the plasma
membrane, a reduction in protein degradation and an altered
protein compartmentalization (Ambrosini et al., 2014).
Kir3-GIRK
The G-protein-coupled Kir (GIRK) channels belong to the
subfamily of Kir3 that are important regulators of electrical
excitability in both cardiomyocytes and neurons (Slesinger et al.,
1995). Different types of neurotransmitters, such as acetylcholine,
dopamine, opioids, serotonin, somatostatin, adenosine, and
GABA, activate these channels by stimulating their G-protein
coupled receptors (GPCRs). This results in a final membrane
hyperpolarization and inhibition of cell excitability due to the
activation of an outward flux of K+ ions (Krapivinsky et al.,
1995; Slesinger et al., 1995). Mammals express four GIRK channel
subunits (GIRK1-4, also named Kir3.1-3.4), encoded by KCNJ3,
KCNJ6, KCNJ9, and KCNJ5, respectively. These four subunits
can form homo or heterotetramers with unique biophysical
properties, regulation and distribution (Lüscher and Slesinger,
2010).
Alterations in GIRK channel function have been associated
with pathophysiology of severe brain disorders, including
epilepsy. In this regard, a GIRK2 knockout mouse model resulted
to be more susceptible to develop both spontaneous or induced
seizures in respect to wild type mice (Signorini et al., 1997). In
particular, mice carrying a p.Gly156Ser mutation displayed an
epileptic phenotype (Patil et al., 1995). Indeed, this mutation has
been found to alter the putative ion-permeable, pore-forming
domain of the channel, inducing Ca2+ overload in cells and
reducing channel availability, leading thus to neurodegeneration
and seizures susceptibility (Slesinger et al., 1996).
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An increased expression of GIRK channels was observed in
rat brain after an electroconvulsive shock, probably altering the
excitability of granule cells and the functions of neurotransmitter
receptors which are coupled to these channels (Pei et al., 1999).
Another evidence in support of a role of GIRK channels in
epilepsy was provided by the demonstration that ML297, a potent
and selective activator of GIRK channels, showed epileptogenic
properties in mice (Kaufmann et al., 2013). On the other hand,
the inhibition of GIRK channel activity by drugs causes seizures
(Mazarati et al., 2006). All these considerations imply that
changes in Kir3 channel activity may alter the susceptibility to
seizures.
Kir4
Among Kir4 channels, the Kir4.1, encoded by the KCNJ10 gene,
is the only one that has been associated to epilepsy. This subunit
can assemble itself in homomeric channels or it can constitute
heterotetramers in combination with Kir5.1 (KCNJ16) (Pessia
et al., 2001). Kir4.1 expression has been detected primarily in
the thalamus, cortex, brainstem and hippocampus (Higashi et al.,
2001). Kir4.1 channels play a key role in maintaining resting
membrane potential by transporting K+ from the extracellular
space into glial cells in the CNS (Nishida and MacKinnon,
2002).
Alterations of Kir4.1 channels have been linked to seizure
susceptibility in both mice (Ferraro et al., 2004) and humans
(Buono et al., 2004). Conditional Kir4.1 knockout mice in
astrocytes have been found to display premature lethality
and severe seizures prior to death (Djukic et al., 2007),
supporting the idea of a pathophysiological relationship of the
Kir4.1 impairment with epilepsy. Concerning human Kir4.1,
a linkage study identified a missense variation (p.Arg271Cys)
as associated with epileptic phenotypes (Buono et al., 2004).
However, the variant did not result to have functional
effects in vitro (Shang et al., 2005). Mutations in this
gene were also reported in EAST syndrome (also named
SeSAME) patients, a rare condition showing epileptic seizures
among other signs (Bockenhauer et al., 2009; Scholl et al.,
2009; Freudenthal et al., 2011; see Table 2 for mutation
details).
Single nucleotide variations in Kir4.1 were detected in the
DNA of TLE patients presenting with hippocampal sclerosis and
antecedent febrile seizures, supporting the importance of KCNJ10
as a candidate gene for seizures susceptibility (Heuser et al.,
2010).
Interestingly, several authors reported a strong association
between epilepsy and autism spectrum disorders (ASDs) and
an “autism-epilepsy phenotype” has been proposed (Tuchman
et al., 2009; Lee et al., 2015). Indeed, a mutational screening of
KCNJ10 in 52 children affected by cryptogenic epilepsy identified
two heterozygous mutations (p.Arg18Gln and p.Val84Met) in
three children of two unrelated families displaying seizures,
ASDs, and intellectual disability. The functional consequences of
these mutations appeared to be a gain-of-function mechanism.
These findings suggest that an abnormal K+ homeostasis in the
brain may increase the susceptibility to this “autism-epilepsy
phenotype” (Sicca et al., 2011). A common mechanism between
autism and epilepsy could be the impairment of astrocytic-
dependent K+ buffering, altering neuronal excitability and
synaptic function.
Kir6-KATP
The adenosine triphosphate (ATP)-sensitive K+ (KATP) channels
are widely distributed in various tissues where they couple cell
metabolism to cell excitability. These channels are assembled
by an inward rectifier K+ channel pore (Kir6.1/Kir6.2) and an
ATP-binding regulatory subunit, named sulfonylurea receptor
(SUR1/SUR2A/SUR2B) (Olson and Terzic, 2010). Neuronal
KATP channels are mainly constituted by a coassembly of
Kir6.2/SUR1 subunits. (Inagaki et al., 1995).
Several gain-of-function mutations were detected in the Kir6.2
(KCNJ11) or the SUR1 subunit (ABCC8). These mutations
are responsible for developmental delay, epilepsy and neonatal
diabetes (DEND), accounting for approximately 40% of cases
and caused a decrease in the ability of ATP to block the KATP
channel. This results in more fully openings of the channel at
physiologically relevant concentrations of ATP, thus increasing
the KATP current (Hattersley and Ashcroft, 2005). Nevertheless,
the pathophysiological mechanism leading to epilepsy remains to
be elucidated. Probably, elevated levels of extracellular glucose
and intracellular ATP attenuate KATP channels, producing a
more excitable state (Huang et al., 2007). Moreover, mice lacking
Kir6.2 are vulnerable to hypoxia, exhibiting a reduced threshold
for generalized seizure (Yamada et al., 2001). Transgenic
mice, overexpressing the SUR1 gene in the forebrain, show a
significant increase in the threshold for kainate-induced seizures
(Hernández-Sánchez et al., 2001).
SODIUM-ACTIVATED POTASSIUM
CHANNELS (KNa)
The Na+-activated K+ channels (KNa) are found in neurons
throughout the brain and are responsible for delayed outward
currents named IKNa. These currents regulate neuronal
excitability and the rate of adaption in response to repeated
stimulation at high frequencies. In many cases, IKNa is mediated
by the phylogenetically related KNa channel subunits Slack
and Slick (Bhattacharjee and Kaczmarek, 2005). Like the Kv
channels, these subunits have six hydrophobic, transmembrane
segments (S1–S6) with a pore P-domain between S5 and S6
and a large cytoplasmatic C-terminal domain containing two
regulators of K+ conductance (RCK) domains that are likely to
be sites for Na+-binding and channel gating. The Slack subunit
binds with Slick to form heterotetrameric channel complexes
(Kaczmarek, 2013). Slack has been associated with different
epilepsy phenotypes.
SLACK
The KCNT1 gene encodes the KNa channel subunit KCNT1,
called Slack (sequence like a calcium-activated potassium
channel, also known as KCa4.1 or Slo2.2). KCNT1 is highly
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expressed in the brain but also in the heart and the kidney at lower
levels. Concerning brain, it is not widely expressed in the cortex
but it is found in neurons of the frontal cortex (Bhattacharjee
et al., 2002), consistent with its known role in the pathogenesis of
autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)
(Heron et al., 2012). While KCNT1 channels are thought to play
important roles in modulating the firing patterns and general
excitability of many types of neurons, their precise function is yet
to be resolved.
Mutations in KCNT1 gene have been found in different
epilepsy syndromes: ADNFLE (Heron et al., 2012; Kim et al.,
2014; Møller et al., 2015), epilepsy of infancy with migrating
focal seizures (EIMFS, previously known as malignant migrating
partial seizures in infancy, MMPSI or also more recently as
malignant migrating focal seizures of infancy, MMFSI) (Barcia
et al., 2012; Ishii et al., 2013; Ohba et al., 2015; Rizzo et al., 2016)
and other types of EOEEs, (Vanderver et al., 2014; Ohba et al.,
2015), including Ohtahara syndrome (OS) (Martin et al., 2014).
The involvement of KCNT1 in these distinct disorders suggests
that KCNT1 mutations may cause a spectrum of focal epilepsies
(Møller et al., 2015). Patients displaying KCNT1 mutations
have a very high occurrence of severe mental and intellectual
disability.
Four missense mutations (p.Arg398Gln, p.Tyr796His,
p.Met896Ile, and p.Arg928Cys) in KCNT1 gene were reported
to be associated with ADNFLE cases showing comorbidities
of intellectual disability and psychiatric features (Heron et al.,
2012). This is in contrast to ADNFLE patients without mutations
in KCNT1 gene, where intelligence and other neurologic
functions are largely unimpaired (Phillips et al., 1998). Mutations
are clustered around the RCK and cytoplasmatic NAD+
binding domain (Heron et al., 2012), the site that regulates
the channel sensitivity to Na+ intracellular concentrations
(Tamsett et al., 2009). A complete penetrance is reported in
ADNFLE families showing KCNT1 mutations (Heron et al.,
2012) with the exception of a non-penetrant case (Møller et al.,
2015).
Interestingly, Møller et al. (2015) reported that a KCNT1
mutation (p.Arg398Gln) can lead to either ADNFLE or EIMFS
within the same family, indicating that genotype-phenotype
correlations are not straightforward). Similarly, a more recent
study showed that the p.Gly288Ser mutation could cause both
phenotypes, probably due to genetic modifiers or environmental
factors (Kim et al., 2014). Nevertheless, this association was
unexpected since in vitro studies demonstrated that mutations
associated with MMFSI caused a significantly larger increase in
current amplitude than those associated with ADNFLE (Milligan
et al., 2014).
Concerning EIMFS, in addition to the above mentioned
p.Gly288Ser and p.Arg398Gln, several additional mutations
have been identified, including p.Val271Phe, p.Arg428Gln,
p.Arg474Gln, p.Met516Val, p.Lys629Asn, p.Ile760Met,
p.Pro924Leu and p.Ala934Thr (Barcia et al., 2012; Ishii et al.,
2013; Mikati et al., 2015; Ohba et al., 2015; Rizzo et al., 2016).
These are clustered not only around the RCK and NAD+ binding
domain of the protein, but also within its S5 transmembrane
segment, indicating that the alteration of other regions of KCNT1
could also be pathogenic (Ishii et al., 2013; McTague et al., 2013;
Kim et al., 2014)
Finally, two KCNT1 mutations were associated with other
forms of EOEEs, strengthening once again the existence of a wide
phenotypic spectrum of KCNT1 mutations. In particular, the
p.Phe932Ile was detected in a patient affected by EOEEs whereas
the p.Ala966Thr was found in one showing OS. Both of them are
clustered around the RCK and NAD+ binding domains of the
protein (Martin et al., 2014; Vanderver et al., 2014; Ohba et al.,
2015).
The effect of nine different mutations in KCNT1 gene that give
rise to these distinct forms of epilepsy was examined and it was
demonstrated that they all result in channels displaying a strong
gain-of-function phenotype: all of them produced many-fold
increases in current amplitude as compared with the wild-type
channel. This could greatly increase the cooperativity in channel
gating that is detected in clusters of multiple channels (Kim et al.,
2014).
CALCIUM-ACTIVATED POTASSIUM
CHANNELS (KCa)
Ca2+-activated K+ channels are highly conserved complexes
thought to play a critical role in neuronal firing properties and
circuit excitability in the human brain. Three groups of Ca2+-
activated K+ channels can be distinguished: large conductance
(BKCa), intermediate conductance (IKCa), and small conductance
(SKCa) channels (N’Gouemo, 2011). The opening of these
channels is in response to an increase in Ca2+ concentration
and a depolarization of the membrane potential, which in
turn causes a secondary hyperpolarization reestablishing the
membrane potential as well as Ca2+ levels. Otherwise it can
produce an afterhyperpolarization to potentials more negative
than the resting membrane potential (Latorre and Brauchi, 2006;
Nardi and Olesen, 2008). To date, only the association between
KCa1.1 channel and epilepsy has been demonstrated.
KCa1.1
KCNMA1 gene encoded the α-subunit of the large conductance
KCa1.1 channels. They show the typical tetrameric structure
of K+ channels, with four α-subunits each displaying seven
transmembrane segments, with a unique S0 segment, and the
charged S4 segment conferring the voltage-dependence. Ca2+
sensitivity comes instead from the bulky C-terminal tail that
includes a negatively charged, high-affinity Ca2+ binding region
(Jiang et al., 2001) and the double negative charged RCK-domain.
These channels could associate with four different types of β
subunits (β1-β4, each encoded by a specific gene KCNMB1-
4) which modulated channel function uniquely (Orio et al.,
2002).
KCa1.1 channels play a role in promoting high neuronal
frequency firing which is consistent with their predominant
expression in axon and presynaptic terminals of neurons located
in brain regions (e.g., hippocampus and cortex) frequently
involved in epilepsy (Gu et al., 2007; Martire et al., 2010).
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The involvement of these channels in epilepsy was suggested not
only by their localization but also by studies on animal models. In
this regard, it has been demonstrated in mice highly susceptible
to convulsions that the inhibition of KCa1.1 channels is sufficient
to block cortical bursting activity (Jin et al., 2000). Moreover,
the loss of β4 subunits in KCaβ4 knockout mice promoted the
excitatory synaptic transmission, resulting in temporal cortex
seizures (Brenner et al., 2005). Finally, Ermolinsky et al. (2008)
demonstrated a deficit of KCNMA1 expression in the dentate
gyrus in animal models, hypothesizing therefore its critical role
in the pathogenesis of mesial temporal lobe epilepsy (mTLE).
An association between KCa1.1 channels and epilepsy has also
been observed in humans. A missense mutation in KCNMA1
(p.Asp434Gly) was detected in a large family with generalized
epilepsy and paroxysmal dyskinesia. Functional studies revealed
an increased Ca2+ sensitivity predicting a gain-of-function
and neuronal hyperexcitability by a presumably faster action
potential repolarization (Du et al., 2005). Additional studies
suggested that depending on the distribution of the various β
subunits in the brain, this mutation can differently modulate
KCa1.1 channels contributing to the pathophysiology of epilepsy
and dyskinesia (Lee and Cui, 2009). As far as genes different
from KCNMA1, a polymorphism in KCNMB4, named rs398702,
was also associated with mTLE in an Irish cohort population
(Cavalleri et al., 2007) but the study failed to be replicated
(Manna et al., 2013), while a truncation mutation in KCNMB3
(p.Val256TyrfsTer4) affecting synaptic inhibition and thereby
increasing neuronal excitability and seizure susceptibility, was
associated with idiopathic generalized epilepsy (Hu et al., 2003;
Lorenz et al., 2007).
CONCLUDING REMARKS
Epilepsy is one of the most common chronic and heterogeneous
neurological disorders, affecting 1–2% of the population,
characterized by recurrent unprovoked seizures due to abnormal
synchronized electrical discharges within the CNS (Steinlein,
2004). Since ion channels mediate the axonal conduction
of action potentials and transduction through synaptic
transmission, increasing evidence suggests that any mutation-
induced channel malfunction directly alter brain excitability
and can induce epileptic seizures. Therefore, the discovery
of genetic defects and, in particular, the electrophysiological
characterization of mutant ion channels in hereditary forms
of epilepsy may elucidate pathophysiological concepts of
hyperexcitability in the CNS. This knowledge could enable
new therapeutic strategies by antagonizing the epilepsy-causing
mechanisms using the defective proteins as pharmacological
targets. Given these considerations, we present an overview
of mutations in K+ channels and their related accessory
subunits underlying different human epileptic phenotypes.
Several families of K+ channels have been involved in the
pathogenesis of epilepsy or other syndromes showing seizures
as a clinical sign. For each channel family, the effect of reported
mutations is different: loss-of-function as well as gain-of-function
could be observed. The common effect of all mutations is
to determine membrane hyperexcitability, thus increasing the
susceptibility to seizures. Our review highlights the pleiotropic
effects of some mutations in K+ channels and the lack of a direct
genotype–phenotype correlation. Interestingly, K+ channels
dysfunctions seem to be mainly observed in epileptic patients
with neurological comorbidities, such as ASDs, intellectual
disabilities or psychiatric features, in which they are associated
with more clinical severity. This observation could suggest to
perform a mutation screening of K+ channels in patients showing
intellectual disabilities.
In conclusion, the discovery of K+ channels encoding genes
that influence susceptibility and disease progression will provide
insight into the molecular events of epileptogenesis, improve
molecular diagnostic utility, and identify novel therapeutic
targets for treatment of human epilepsy.
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